Jeffrey McCullough - Transfusion Medicine

74 74. Stroncek DF, Clay ME, Herr G, et al. The kinetics of G‐CSF mobilization of CD34+ cells in healthy people. Transfus Med 1997; 7:19–24.

75 75. Lightfoot T, Leitman SF, Stroncek DF. Storage of G‐CSF‐mobilized granulocyte concentrates. Transfusion 2000; 40:1104–1110.

76 76. Djerassi I, Kim JS, Suvansri U, et al. Continuous flow filtration—leukopheresis. Transfusion 1972; 12:75–83.

77 77. McCullough J, Weiblen BJ, Deinard AR, et al. In vitro function and post‐transfusion survival of granulocytes collected by continuous‐flow centrifugation and by filtration leukapheresis. Blood 1976; 48:315–326.

78 78. Wright DG, Kauffmann JC, Chusid MJ, et al. Functional abnormalities of human neutrophils collected by continuous flow filtration leukopheresis. Blood 1975; 46:901–911.

79 79. Schiffer CA, Aisner J, Wiernik PH. Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters. Blood 1975; 45:141–146.

80 80. Rubins JL, MacPherson JL, Nusbacher J, Wiltbank T. Granulocyte kinetics in donors undergoing filtration leukapheresis. Transfusion 1976; 16:56–62.

81 81. Hammerschmidt DE, Craddock PR, McCullough J, et al. Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis. Blood 1978; 51:721–730.

82 82. Nusbacher J, Rosenfeld SI, MacPherson JL, et al. Nylon fiber leukapheresis: associated complement component changes and granulocytopenia. Blood 1978; 51:359–365.

83 83. Wiltbank TB, Nusbacher J, Higby DJ, MacPherson JL. Abdominal pain in donors during filtration leukapheresis. Transfusion 1977; 17:159–162.

84 84. Glasser L, Huestis DW, Jones JF. Functional capabilities of steroid‐recruited neutrophils harvested for clinical transfusion. N Engl J Med 1977; 297:1033.

85 85. Glasser L. Functional considerations of granulocyte concentrates used for clinical transfusions. Transfusion 1979; 19:1.

86 86. Strauss RG, Maguire LC, Koepke JA, Thompson JS. Properties of neutrophils collected by discontinuous‐flow centrifugation leukapheresis employing hydroxyethyl starch. Transfusion 1979; 19:192.

87 87. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method, donor corticosteroid treatment, and short term storage. Blood 1979; 54:977.

88 88. McCullough J, Weiblen BJ, Fine D. Effects of storage of granulocytes on their fate in vivo. Transfusion 1983; 23:20.

89 89. Dutcher JP, Schiller CA, Johston GS, et al. The effect of histocompatibility factors on the migration of transfused 111indium‐labeled granulocytes (abstract). Blood 1984; 58:181.

90 90. Glasser L. Effect of storage on normal neutrophils collected by discontinuous‐flow centrifugation leukapheresis. Blood 1977; 50:1145.

91 91. McCullough J. Liquid preservation of granulocytes. Transfusion 1980; 20:129.

92 92. McCullough J, Clay ME, Loken MK, Hurd JJ. Effect of ABO incompatibility on fate in vivo of 111indium granulocytes. Transfusion 1988; 28:358.

93 93. Eyre HJ, Goldstein IM, Perry S, Graw RG Jr. Leukocyte transfusions: function of transfused granulocytes from donors with chronic myelocytic leukemia. Blood 1970; 36:432.

94 94. Applebaum FR, Trapani RJ, Graw RG. Consequences of prior alloimmunization during granulocyte transfusion. Transfusion 1977; 17:460.

95 95. McCullough J, Clay M, Hurd D, et al. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111indium granulocytes. Blood 1986; 67:522.

96 96. Dutcher JP, Fox JJ, Riggs C, et al. Pulmonary retention of indium‐111‐ labeled granulocytes in alloimmunized patients. Blood 1982; 58:171 (abstract).

97 97. Pettengell R, Morgenstern GR, Woll PJ, et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993; 82:3770–3777.

98 98. Welte K, Gabrilove J, Bronchud MH, et al. Filgrastim (r‐metHuG‐CSF): the first 10 years. Blood 1996; 88:1907–1929.

99 99. Brandt SJ, Peters WP, Atwater SK, et al. Effect of recombinant human granulocyte‐macrophage colony‐stimulating factor on hematopoietic reconstitution after high‐dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318:869–876.

100 100. Bishop MR, Anderson JR, Jackson JD, et al. High‐dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte‐macrophage colony‐stimulating factor on the autograft. Blood 1994; 83:610–616.

101 101. Nemunaitis J, Rabinowe SN, Singer JW, et al. Recombinant granulocyte‐macrophage colony‐stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 1991; 324:1773–1778.

102 102. Bensinger W, Singer J, Appelbaum F, et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81:3158–3163.

103 103. Korbling M, Huh YO, Durett A, et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor‐derived primitive hematopoietic progenitor cells (CD34+ Th‐1dim) and lymphoid subsets, and possible predictors of engraftment and graft‐versus‐host disease. Blood 1995; 86:2842–2848.

104 104. Bensinger WI, Clift RA, Anasetti C, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 1996; 14:90–105.

105 105. Bensinger WI, Buckner CD, Shannon‐Dorcy K, et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996; 88:4132–4138.

106 106. Nemunaitis J, Anasetti C, Storb R, et al. Phase II trial of recombinant human granulocyte‐macrophage colony‐stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. Blood 1992; 79:2572–2577.

107 107. Korbling M, Przepiorka D, Huh YO. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85:1659–1665.

108 108. Lickliter JD, McGlave PB, DeFor TE, et al. Matched‐pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Bone Marrow Transplant 2000; 26:723–728.

109 109. Schmitz N, Beksac M, Hasenclever D, et al. Transplantation of mobilized peripheral blood cells to HLA‐identical siblings with standard‐risk leukemia. Blood 2002; 100:761–767.

110 110. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97:3380–3389.

111 111. Weaver CH, Buckner CD, Longin K. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony‐stimulating factor. Blood 1993; 82:1981–1984.

112 112. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85:1413–1415.

113 113. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony‐stimulating factor). Blood 1995; 86:1666–1672.

114 114. Hillyer CE, Lackey DA, Hart KK, et al. CD34+ progenitors and colony‐forming units—granulocyte macrophages are recruited during large‐volume leukapheresis and concentrated by counterflow centrifugal elutriation. Transfusion 1993; 33:316–321.

115 115. Stroncek DF, Clay ME, Smith J, et al. Composition of peripheral blood progenitor cell components collected from healthy donors. Transfusion 1997; 37:411–417.

116 116. Korbling M, Przepiorka D, Gajewski J, et al. With first successful allogeneic transplantations of apheresis‐derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? Blood 1995; 86:1235–1239.